ASAN 2026 Conference Certificate and Survey

Enter the code to activate the survey

Name

First NameLast Name

Email

example@example.com

Cell Phone

Please enter a valid phone number.Format: (000) 000-0000.

Location

Street Address

Street Address Line 2

CityState

How did you hear about the conference? Select all that apply

How would you rate the following aspects of this meeting? (Leave blank if you did not attend the specified event/activity)

Rows	1 = (poor)	2	3	4 = (excellent)
Content
Overall Quality of Speakers
Organization/Planning
Online Registration
Helpfulness of Staff in advance of the conference (email notifications and updates)
Helpfulness of Staff during the conference
Opportunities for interaction/networking
Exhibit Area access/availability
Free time to "explore the area"

How would you rate the following activities of this meeting? (Leave blank if you did not attend the specified event/activity)

Rows	1 = (poor)	2	3	4 = (excellent)
Thursday AM Break
Thursday Lunch
Thursday PM BreakSaturday Lunch
Thursday Evening Reception
Friday AM Break
Friday Lunch
Friday PM Break
Friday Poster Reception
Saturday AM Break

Please add general comments, what would you like to see added, taken away, general impressions of the event, etc.

When rating the conference presentations, rate the effectiveness of the presenter(s) and whether the objectives were met using the following scale:

1 = strongly disagree/poor
2
3
4 = strongly agree/excellent

Wednesday Workshop. Psychopharmacology: An Overview in the Treatment of Substance Use and Co-Occurring Disorders

Psychopharmacology: An Overview in the Treatment of Substance Use and Co-Occurring Disorders

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
William J. Lorman was an effective presenter for this topic.
Understand the scientific basis of chemical neurotransmission and how drugs may modify chemical neurotransmission by interacting with receptors and enzymes.
Understand how abnormalities in neurotransmission underlie major psychiatric disorders.
Understand the unique psychopharmacological mechanisms of action of the major antidepressants, anxiolytics, antipsychotics, cognitive enhancing agents, and drugs of abuse.
Be knowledgeable of the mechanism of therapeutic action versus the side effects of the major members of each class of psychotropic agents.

Wednesday Workshop - please share your comments about this presentation

Session 1. Rewiring Recovery: Using Neuroscience and Micro-Habits to Improve Outcomes in Addiction Treatment

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Ken J Martz was an effective presenter for this topic.
Explain the role of neuroplasticity in addiction, withdrawal, and early recovery and how habits form and change at the neural level.
Identify key micro-habits that support stabilization, emotional regulation, and long-term recovery across inpatient, outpatient, and community settings.
Apply at least three neuroscience-informed strategies, including habit stacking, emotional reset practices, and cue interruption to help patients build healthier behavioral patterns and improve treatment outcomes.

Session 1 - please share your comments about this presentation

Session 2. 9-EPD. A Mobile Street Clinical Immersion Experience for Nursing Students in Drug "Hot Spot" Communities in Baltimore City

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Mary E Lashley was an effective presenter for this topic.
Identify three essential components of a recovery centered mobile street outreach program.
Evaluate the impact of a mobile street outreach clinical immersion experience on nursing students' perceptions of persons experiencing homelessness and chemical addictions and their willingness to engage with marginalized populations.
Discuss three pedagogical challenges to the implementation of a mobile street outreach clinical experience.

Session 2 - please share your comments about this presentation

Session 3. 12-EPD. Under 25 Substance Use: Trends and Treatment

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Ashton Doby Tisdale was an effective presenter for this topic.
Identify current substance use trends in adolescents and young adults under the age of 25.
Recognize substances of current popularity and methods of use among adolescents and young adults under the age of 25.
Analyze evidence based practices in recovery management specific to treatment of adolescents and young adults under the age of 25.

Session 3 - please share your comments about this presentation

Session 4. 6-CEP. Mind Reboot: Getting Your Cognitive Edge Back After Substance Use

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Christina Jones was an effective moderator for this topic.
Learn how early recovery impacts the brain in terms of executive functioning.
Develop strategies to strengthen executive functioning.
Gain an awareness of what PAWS looks like: post acute withdrawal symptoms
Gain resources to assist students/clients with the recovery process.

Session 4 - please share your comments about this presentation

Session 5. 23-P. The Facts About Medications for Addiction Treatment

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
MaryAnne Christine Murray was an effective presenter for this topic.
Identify three medications a primary care provider can prescribe for patients with Opioid Use Disorders (OUDs), and one that a PCP cannot prescribe.
Describe the proper way to administer Naloxone (Narcan), a rescue medication.
Discuss three medications which are FDA approved for treating Alcohol Use Disorder (AUDs).

Session 5 - please share your comments about this presentation

Session 6. Long-Acting Injectable Medications for Opioid Use Disorder Workshop

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
EM Vitug Garcia was an effective presenter for this topic.
Benjamin Mahoney was an effective presenter for this topic.
describe the pharmacology and indications for use of long-acting injectable medications for substance use disorders.
Obtain basic competency in the administration technique of long-acting injectable medications for substance use disorders.

Session 6 - please share your comments about this presentation

Session 7. Championing Women’s Hormonal Issues in SUD Treatment Planning

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Eileen Newton was an effective presenter for this topic
Describe the impact of biological gender differences, including the roles of estrogen and progesterone, on substance use disorder vulnerability, the telescoping effect, and relapse risk in women.
Identify current gender-based disparities in substance use disorder prevalence, treatment access, and medication-assisted treatment utilization.
Apply person-first language, motivational interviewing principles, and stigma-reduction strategies when providing gender-responsive nursing care to women with substance use disorder.

Session 7 - please share your comments about this presentation

Session 8. 28-EPD. Moral Resilience in Practice: Caring for Patients with Substance Use Disorders

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Theresa Marie Fay-Hillier was an effective presenter for this topic.
Hyeyeon "Hailey" Park was an effective presenter for this topic.
Susan M. Solecki was an effective presenter for this topic.
Define moral distress and moral resilience and identify at least two risk factors that contribute to moral distress when caring for patients with substance use disorders.
Identify ethical stressors encountered when caring for patients who screen positive for substance use disorders.
Implement at least two strategies to develop moral resilience and support professional sustainability in addiction nursing practice.

Session 8 - please share your comments about this presentation

Session 9. 7-LA. Calm in the Chaos: Emotional Mastery Skills for Nurses Working in High-Intensity Addiction Settings

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Ken Martz was an effective presenter for this topic.
Describe how stress and neurobiological activation impact clinical judgment, communication, and patient interactions in addiction care settings.
Identify signs of emotional reactivity, compassion fatigue, and secondary trauma that can influence safety, boundaries, and treatment outcomes.
Apply at least three emotional mastery strategies including grounding techniques, mindful micro-resets, and trauma-informed communication to maintain calm and enhance excellence in high-intensity nursing environments.

Session 9 - please share your comments about this presentation

Session 10. 19-EPD. Colleague to Colleague - A Three Step Approach to Addressing Suspected Substance Use Problems in the Workplace

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Carol E Mallia was an effective presenter for this topic.
Explore the common signs and symptoms of impaired practice, including data gathered from automated medication delivery systems.
Describe the simple three step approach for addressing suspected substance use problems in the workplace and encouraging recovery treatment.
Explore how to compassionately address substance use in the workplace.

Session 10 - please share your comments about this presentation

Session 11. 16-CEP. Ethical Considerations in the Involuntary Admission of Individuals with Dual Diagnosis

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Amy Marie Funk was an effective presenter for this topic.
Understand exemplar criteria for involuntary admission.
Identify potential ethical issues within the involuntary admission process.
Use an ethical framework to evaluate relevant ethical case studies.
Identify interventions that improve outcomes in involuntary admission.

Session 11 - please share your comments about this presentation

Session 12. 31-CEP. Gender Responsive Treatment: A Model Program Helping Pregnant and Parenting Women to Thrive!

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Eileen Newton was an effective presenter for this topic.
Describe the process by which a project can move from conceptualization to grant writing to construction and program completion.
Discuss the critical role of Addiction Nurses in supporting pregnant and parenting women along the continuum from addiction to recovery.
State three benefits women can achieve in a successful pregnant and parenting women’s program.

Session 12 - please share your comments about this presentation

Poster Session

Confirm the quality of the following posters

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent	Poster was not available
2-P. Initiation of Buprenorphine in Outpatient Settings
4-CEP. The importance of understanding and addressing the unique needs of women with opioid use disorder as a factor in successful treatment
10-CEP. Nurse-led Collaborative Care Model Strengthens Addiction Medicine Treatment and Patient Retention
18-EPD. The Sentinel-NPS Recognition Framework: Designing an Evidence-Based Toolkit for Addiction Nursing Education
24-EPD. Bridging the Gap: Assessing Nurses' Preparedness to Care for Patients with Substance Use Disorder
29-EPD. Changing Hearts and Minds: Partnering with the Recovery Community to Bring Authenticity and Lived Experience to Addictions-Focused Simulations

Session 13. 25-CEP. The Connected FQHC: Making Mental Health and Substance Use Part of Everyday Primary Care

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Alissa Strambler-Rio was an effective presenter for this topic.
Describe the importance of integrating mental health, substance use treatment, and opioid use disorder management into primary services within FQHCs, with emphasis on the nurse practitioner’s role in whole‑person care.
Explain evidence‑based approaches for screening, diagnosing, and treating opioid use disorder in primary care, including the pharmacology of buprenorphine/naloxone (Suboxone) and its use within OBMAT programs.
Apply ethical principles (autonomy, beneficence, non‑maleficence, justice) to integrated primary care for patients with OUD and co‑occurring conditions, including initiation and maintenance of buprenorphine/naloxone (Suboxone).

Session 13 - please share your comments about this presentation

Session 14. 17-CEP. Acute Care Management of Substance use Disorders: Evidence-Based Strategies for Screening, Neurobiology, and Emerging Pharmacological Interventions

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Sandra Jean Cagle was an effective presenter for this topic
Analyze the neurobiology of addiction, specifically the role of the mesolimbic reward system and prefrontal cortex in drug seeking behaviors.
Evaluate evidence-based screening tools, such as SBIRT and NM-ASSIST, to identify and assess patients with alcohol, nicotine, and opioid use disorders in acute care settings.
Identify emerging pharmacological practices, including microdosing buprenorphine induction and the role of thiamine and magnesium repletion in managing alcohol withdrawal.

Session 14 - please share your comments about this presentation

Session 15. 11-CEP. Applying evidence based harm reduction strategies to reduce vascular complications associated with intravenous drug use

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Kurt Haspert was an effective presenter for this topic
Differentiate between the causes, treatment, and complications arising from arterial and venous vascular injuries
Describe three evidence based harm reduction activities to reduce the incidence of vascular injuries in intravenous drug users.
Synthesize research identifying specific barriers among healthcare providers in implementing harm reduction methods for intravenous drug users.

Session 15 - please share your comments about this presentation

Session 16. New Landscape of Mood-altering Drugs; Emerging Drugs and Substance Use in Nursing

Rows	1 = strongly disagree/poor	2	3	4 = strongly agree/excellent
Abby Migliore was an effective presenter for this topic
Recognize prevalence of substance abuse in nursing.
Define Emerging Drugs.
Recognize rates types of Emerging Drugs.
Discuss different Emerging Drugs and how they are being used.
Discuss the prevalence of Cannabis and impact on safety sensitive jobs.

Session 16 - please share your comments about this presentation

NursingCE

PharmacologyWednesdayWorkshop

PharmacologySession5

PharmacologySession6

PharmacologyCE

ASAN 2026 Annual Conference